- Home
- DARE vs BODI Comparison
DARE vs BODI Comparison
Compare DARE & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- BODI
- Stock Information
- Founded
- DARE 2015
- BODI 1998
- Country
- DARE United States
- BODI United States
- Employees
- DARE N/A
- BODI N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- BODI Industrial Machinery/Components
- Sector
- DARE Health Care
- BODI Industrials
- Exchange
- DARE Nasdaq
- BODI Nasdaq
- Market Cap
- DARE 26.3M
- BODI 25.4M
- IPO Year
- DARE N/A
- BODI N/A
- Fundamental
- Price
- DARE $2.44
- BODI $4.03
- Analyst Decision
- DARE Strong Buy
- BODI Strong Buy
- Analyst Count
- DARE 3
- BODI 3
- Target Price
- DARE $12.50
- BODI $10.67
- AVG Volume (30 Days)
- DARE 38.9K
- BODI 95.2K
- Earning Date
- DARE 08-11-2025
- BODI 08-05-2025
- Dividend Yield
- DARE N/A
- BODI N/A
- EPS Growth
- DARE N/A
- BODI N/A
- EPS
- DARE N/A
- BODI N/A
- Revenue
- DARE $25,909.00
- BODI $371,113,000.00
- Revenue This Year
- DARE $99,756.91
- BODI N/A
- Revenue Next Year
- DARE $119.77
- BODI N/A
- P/E Ratio
- DARE N/A
- BODI N/A
- Revenue Growth
- DARE N/A
- BODI N/A
- 52 Week Low
- DARE $2.35
- BODI $3.38
- 52 Week High
- DARE $4.60
- BODI $9.40
- Technical
- Relative Strength Index (RSI)
- DARE 35.15
- BODI 49.45
- Support Level
- DARE $2.37
- BODI $3.75
- Resistance Level
- DARE $2.54
- BODI $4.43
- Average True Range (ATR)
- DARE 0.11
- BODI 0.26
- MACD
- DARE -0.02
- BODI 0.04
- Stochastic Oscillator
- DARE 17.50
- BODI 47.88
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.